Colistimethate Sodium Noridem is an antibiotic inhaled to treat chronic lung infections in cystic fibrosis patients caused by the Pseudomonas aeruginosa bacteria.
For adults, adolescents, and children aged 2 years and above, the typical dose is 1–2 million units two or three times daily. For children under 2 years, the typical dose is 0.5–1 million units twice daily.
This medicine is inhaled into the lungs using a nebuliser.
The maximum daily dose is 6 million units for those aged 2 years and above, and 2 million units for children under 2 years.